0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucocorticoid Injection Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-2Y17318
Home | Market Reports
Global Glucocorticoid Injection Market Research Report 2024
BUY CHAPTERS

Global Glucocorticoid Injection Market Research Report 2026

Code: QYRE-Auto-2Y17318
Report
2026-04-10
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Glucocorticoid Injection Market

The global Glucocorticoid Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Glucocorticoid Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Corticosteroid injections are a commonly used form of medication used to provide fast, effective treatment results. Glucocorticoids are a class of drugs with anti-inflammatory, immunosuppressive and anti-allergic effects and are widely used in the treatment of a variety of diseases. Glucocorticoids can be divided into three categories: short-acting, medium-acting and long-acting according to their duration of action.
The North American market for Glucocorticoid Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Glucocorticoid Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Glucocorticoid Injection include Pfizer, SiNi Pharma, Wellona Pharma, AdvaCare Pharma, Eurocrit Labs, Pyxus Pharmaceutical, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Caspian Tamin Pharmaceutical Company, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Glucocorticoid Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Glucocorticoid Injection. The Glucocorticoid Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Glucocorticoid Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Glucocorticoid Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Glucocorticoid Injection Market Report

Report Metric Details
Report Name Glucocorticoid Injection Market
Segment by Type
  • Beclomethasone Injection
  • Betamethasone Injection
  • Budesonide Injection
  • Cortisone Injection
  • Dexamethasone Injection
  • Hydrocortisone Injection
  • Methylprednisolone Injection
  • Prednisolone Injection
by Application
  • Rheumatoid Arthritis
  • Allergic Diseases
  • Bronchial Asthma
  • Autoimmune Disease
  • Skin Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, SiNi Pharma, Wellona Pharma, AdvaCare Pharma, Eurocrit Labs, Pyxus Pharmaceutical, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Caspian Tamin Pharmaceutical Company, Cipla Ltd, Nexphex Global Pharma Private Limited, Criticine Care, Nephron Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Glucocorticoid Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Glucocorticoid Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Glucocorticoid Injection Market report?

Ans: The main players in the Glucocorticoid Injection Market are Pfizer, SiNi Pharma, Wellona Pharma, AdvaCare Pharma, Eurocrit Labs, Pyxus Pharmaceutical, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Caspian Tamin Pharmaceutical Company, Cipla Ltd, Nexphex Global Pharma Private Limited, Criticine Care, Nephron Pharmaceuticals

What are the Application segmentation covered in the Glucocorticoid Injection Market report?

Ans: The Applications covered in the Glucocorticoid Injection Market report are Rheumatoid Arthritis, Allergic Diseases, Bronchial Asthma, Autoimmune Disease, Skin Diseases, Others

What are the Type segmentation covered in the Glucocorticoid Injection Market report?

Ans: The Types covered in the Glucocorticoid Injection Market report are Beclomethasone Injection, Betamethasone Injection, Budesonide Injection, Cortisone Injection, Dexamethasone Injection, Hydrocortisone Injection, Methylprednisolone Injection, Prednisolone Injection

1 Glucocorticoid Injection Market Overview
1.1 Product Definition
1.2 Glucocorticoid Injection by Type
1.2.1 Global Glucocorticoid Injection Market Value by Type: 2025 vs 2032
1.2.2 Beclomethasone Injection
1.2.3 Betamethasone Injection
1.2.4 Budesonide Injection
1.2.5 Cortisone Injection
1.2.6 Dexamethasone Injection
1.2.7 Hydrocortisone Injection
1.2.8 Methylprednisolone Injection
1.2.9 Prednisolone Injection
1.3 Glucocorticoid Injection by Application
1.3.1 Global Glucocorticoid Injection Market Value by Application: 2025 vs 2032
1.3.2 Rheumatoid Arthritis
1.3.3 Allergic Diseases
1.3.4 Bronchial Asthma
1.3.5 Autoimmune Disease
1.3.6 Skin Diseases
1.3.7 Others
1.4 Global Glucocorticoid Injection Market Size Estimates and Forecasts
1.4.1 Global Glucocorticoid Injection Revenue 2021–2032
1.4.2 Global Glucocorticoid Injection Sales 2021–2032
1.4.3 Global Glucocorticoid Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Glucocorticoid Injection Market Competition by Manufacturers
2.1 Global Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Glucocorticoid Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Glucocorticoid Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Glucocorticoid Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Glucocorticoid Injection, Product Types and Applications
2.7 Global Key Manufacturers of Glucocorticoid Injection, Date of Entry into the Industry
2.8 Global Glucocorticoid Injection Market Competitive Situation and Trends
2.8.1 Global Glucocorticoid Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Glucocorticoid Injection Players Market Share by Revenue
2.8.3 Global Glucocorticoid Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucocorticoid Injection Market Scenario by Region
3.1 Global Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Glucocorticoid Injection Sales by Region: 2021–2032
3.2.1 Global Glucocorticoid Injection Sales by Region: 2021–2026
3.2.2 Global Glucocorticoid Injection Sales by Region: 2027–2032
3.3 Global Glucocorticoid Injection Revenue by Region: 2021–2032
3.3.1 Global Glucocorticoid Injection Revenue by Region: 2021–2026
3.3.2 Global Glucocorticoid Injection Revenue by Region: 2027–2032
3.4 North America Glucocorticoid Injection Market Facts & Figures by Country
3.4.1 North America Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Glucocorticoid Injection Sales by Country (2021–2032)
3.4.3 North America Glucocorticoid Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucocorticoid Injection Market Facts & Figures by Country
3.5.1 Europe Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Glucocorticoid Injection Sales by Country (2021–2032)
3.5.3 Europe Glucocorticoid Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucocorticoid Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Glucocorticoid Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Glucocorticoid Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucocorticoid Injection Market Facts & Figures by Country
3.7.1 Latin America Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Glucocorticoid Injection Sales by Country (2021–2032)
3.7.3 Latin America Glucocorticoid Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Glucocorticoid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Glucocorticoid Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Glucocorticoid Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucocorticoid Injection Sales by Type (2021–2032)
4.1.1 Global Glucocorticoid Injection Sales by Type (2021–2026)
4.1.2 Global Glucocorticoid Injection Sales by Type (2027–2032)
4.1.3 Global Glucocorticoid Injection Sales Market Share by Type (2021–2032)
4.2 Global Glucocorticoid Injection Revenue by Type (2021–2032)
4.2.1 Global Glucocorticoid Injection Revenue by Type (2021–2026)
4.2.2 Global Glucocorticoid Injection Revenue by Type (2027–2032)
4.2.3 Global Glucocorticoid Injection Revenue Market Share by Type (2021–2032)
4.3 Global Glucocorticoid Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Glucocorticoid Injection Sales by Application (2021–2032)
5.1.1 Global Glucocorticoid Injection Sales by Application (2021–2026)
5.1.2 Global Glucocorticoid Injection Sales by Application (2027–2032)
5.1.3 Global Glucocorticoid Injection Sales Market Share by Application (2021–2032)
5.2 Global Glucocorticoid Injection Revenue by Application (2021–2032)
5.2.1 Global Glucocorticoid Injection Revenue by Application (2021–2026)
5.2.2 Global Glucocorticoid Injection Revenue by Application (2027–2032)
5.2.3 Global Glucocorticoid Injection Revenue Market Share by Application (2021–2032)
5.3 Global Glucocorticoid Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Glucocorticoid Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 SiNi Pharma
6.2.1 SiNi Pharma Company Information
6.2.2 SiNi Pharma Description and Business Overview
6.2.3 SiNi Pharma Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SiNi Pharma Glucocorticoid Injection Product Portfolio
6.2.5 SiNi Pharma Recent Developments/Updates
6.3 Wellona Pharma
6.3.1 Wellona Pharma Company Information
6.3.2 Wellona Pharma Description and Business Overview
6.3.3 Wellona Pharma Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Wellona Pharma Glucocorticoid Injection Product Portfolio
6.3.5 Wellona Pharma Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Company Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AdvaCare Pharma Glucocorticoid Injection Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Eurocrit Labs
6.5.1 Eurocrit Labs Company Information
6.5.2 Eurocrit Labs Description and Business Overview
6.5.3 Eurocrit Labs Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eurocrit Labs Glucocorticoid Injection Product Portfolio
6.5.5 Eurocrit Labs Recent Developments/Updates
6.6 Pyxus Pharmaceutical
6.6.1 Pyxus Pharmaceutical Company Information
6.6.2 Pyxus Pharmaceutical Description and Business Overview
6.6.3 Pyxus Pharmaceutical Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Pyxus Pharmaceutical Glucocorticoid Injection Product Portfolio
6.6.5 Pyxus Pharmaceutical Recent Developments/Updates
6.7 Zydus Cadila
6.7.1 Zydus Cadila Company Information
6.7.2 Zydus Cadila Description and Business Overview
6.7.3 Zydus Cadila Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zydus Cadila Glucocorticoid Injection Product Portfolio
6.7.5 Zydus Cadila Recent Developments/Updates
6.8 Weefsel Pharma
6.8.1 Weefsel Pharma Company Information
6.8.2 Weefsel Pharma Description and Business Overview
6.8.3 Weefsel Pharma Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Weefsel Pharma Glucocorticoid Injection Product Portfolio
6.8.5 Weefsel Pharma Recent Developments/Updates
6.9 Taj Pharmaceuticals Limited
6.9.1 Taj Pharmaceuticals Limited Company Information
6.9.2 Taj Pharmaceuticals Limited Description and Business Overview
6.9.3 Taj Pharmaceuticals Limited Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Taj Pharmaceuticals Limited Glucocorticoid Injection Product Portfolio
6.9.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.10 Caspian Tamin Pharmaceutical Company
6.10.1 Caspian Tamin Pharmaceutical Company Company Information
6.10.2 Caspian Tamin Pharmaceutical Company Description and Business Overview
6.10.3 Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Product Portfolio
6.10.5 Caspian Tamin Pharmaceutical Company Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Company Information
6.11.2 Cipla Ltd Description and Business Overview
6.11.3 Cipla Ltd Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Cipla Ltd Glucocorticoid Injection Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 Nexphex Global Pharma Private Limited
6.12.1 Nexphex Global Pharma Private Limited Company Information
6.12.2 Nexphex Global Pharma Private Limited Description and Business Overview
6.12.3 Nexphex Global Pharma Private Limited Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Nexphex Global Pharma Private Limited Glucocorticoid Injection Product Portfolio
6.12.5 Nexphex Global Pharma Private Limited Recent Developments/Updates
6.13 Criticine Care
6.13.1 Criticine Care Company Information
6.13.2 Criticine Care Description and Business Overview
6.13.3 Criticine Care Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Criticine Care Glucocorticoid Injection Product Portfolio
6.13.5 Criticine Care Recent Developments/Updates
6.14 Nephron Pharmaceuticals
6.14.1 Nephron Pharmaceuticals Company Information
6.14.2 Nephron Pharmaceuticals Description and Business Overview
6.14.3 Nephron Pharmaceuticals Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Nephron Pharmaceuticals Glucocorticoid Injection Product Portfolio
6.14.5 Nephron Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucocorticoid Injection Industry Chain Analysis
7.2 Glucocorticoid Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucocorticoid Injection Production Mode & Process Analysis
7.4 Glucocorticoid Injection Sales and Marketing
7.4.1 Glucocorticoid Injection Sales Channels
7.4.2 Glucocorticoid Injection Distributors
7.5 Glucocorticoid Injection Customer Analysis
8 Glucocorticoid Injection Market Dynamics
8.1 Glucocorticoid Injection Industry Trends
8.2 Glucocorticoid Injection Market Drivers
8.3 Glucocorticoid Injection Market Challenges
8.4 Glucocorticoid Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Glucocorticoid Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Glucocorticoid Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Glucocorticoid Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Glucocorticoid Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Glucocorticoid Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Glucocorticoid Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Glucocorticoid Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Glucocorticoid Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Glucocorticoid Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Glucocorticoid Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Glucocorticoid Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Glucocorticoid Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Glucocorticoid Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Glucocorticoid Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Glucocorticoid Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Glucocorticoid Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Glucocorticoid Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Glucocorticoid Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Glucocorticoid Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Glucocorticoid Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Glucocorticoid Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Glucocorticoid Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Glucocorticoid Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Glucocorticoid Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Glucocorticoid Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Glucocorticoid Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Glucocorticoid Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Glucocorticoid Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Glucocorticoid Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Glucocorticoid Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Glucocorticoid Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Glucocorticoid Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Glucocorticoid Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Glucocorticoid Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Glucocorticoid Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Glucocorticoid Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Glucocorticoid Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Glucocorticoid Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Glucocorticoid Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Glucocorticoid Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Glucocorticoid Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Pfizer Glucocorticoid Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. SiNi Pharma Company Information
 Table 76. SiNi Pharma Description and Business Overview
 Table 77. SiNi Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. SiNi Pharma Glucocorticoid Injection Product
 Table 79. SiNi Pharma Recent Developments/Updates
 Table 80. Wellona Pharma Company Information
 Table 81. Wellona Pharma Description and Business Overview
 Table 82. Wellona Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Wellona Pharma Glucocorticoid Injection Product
 Table 84. Wellona Pharma Recent Developments/Updates
 Table 85. AdvaCare Pharma Company Information
 Table 86. AdvaCare Pharma Description and Business Overview
 Table 87. AdvaCare Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. AdvaCare Pharma Glucocorticoid Injection Product
 Table 89. AdvaCare Pharma Recent Developments/Updates
 Table 90. Eurocrit Labs Company Information
 Table 91. Eurocrit Labs Description and Business Overview
 Table 92. Eurocrit Labs Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Eurocrit Labs Glucocorticoid Injection Product
 Table 94. Eurocrit Labs Recent Developments/Updates
 Table 95. Pyxus Pharmaceutical Company Information
 Table 96. Pyxus Pharmaceutical Description and Business Overview
 Table 97. Pyxus Pharmaceutical Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Pyxus Pharmaceutical Glucocorticoid Injection Product
 Table 99. Pyxus Pharmaceutical Recent Developments/Updates
 Table 100. Zydus Cadila Company Information
 Table 101. Zydus Cadila Description and Business Overview
 Table 102. Zydus Cadila Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Zydus Cadila Glucocorticoid Injection Product
 Table 104. Zydus Cadila Recent Developments/Updates
 Table 105. Weefsel Pharma Company Information
 Table 106. Weefsel Pharma Description and Business Overview
 Table 107. Weefsel Pharma Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Weefsel Pharma Glucocorticoid Injection Product
 Table 109. Weefsel Pharma Recent Developments/Updates
 Table 110. Taj Pharmaceuticals Limited Company Information
 Table 111. Taj Pharmaceuticals Limited Description and Business Overview
 Table 112. Taj Pharmaceuticals Limited Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Taj Pharmaceuticals Limited Glucocorticoid Injection Product
 Table 114. Taj Pharmaceuticals Limited Recent Developments/Updates
 Table 115. Caspian Tamin Pharmaceutical Company Company Information
 Table 116. Caspian Tamin Pharmaceutical Company Description and Business Overview
 Table 117. Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Caspian Tamin Pharmaceutical Company Glucocorticoid Injection Product
 Table 119. Caspian Tamin Pharmaceutical Company Recent Developments/Updates
 Table 120. Cipla Ltd Company Information
 Table 121. Cipla Ltd Description and Business Overview
 Table 122. Cipla Ltd Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Cipla Ltd Glucocorticoid Injection Product
 Table 124. Cipla Ltd Recent Developments/Updates
 Table 125. Nexphex Global Pharma Private Limited Company Information
 Table 126. Nexphex Global Pharma Private Limited Description and Business Overview
 Table 127. Nexphex Global Pharma Private Limited Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Nexphex Global Pharma Private Limited Glucocorticoid Injection Product
 Table 129. Nexphex Global Pharma Private Limited Recent Developments/Updates
 Table 130. Criticine Care Company Information
 Table 131. Criticine Care Description and Business Overview
 Table 132. Criticine Care Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Criticine Care Glucocorticoid Injection Product
 Table 134. Criticine Care Recent Developments/Updates
 Table 135. Nephron Pharmaceuticals Company Information
 Table 136. Nephron Pharmaceuticals Description and Business Overview
 Table 137. Nephron Pharmaceuticals Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Nephron Pharmaceuticals Glucocorticoid Injection Product
 Table 139. Nephron Pharmaceuticals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Glucocorticoid Injection Distributors List
 Table 143. Glucocorticoid Injection Customers List
 Table 144. Glucocorticoid Injection Market Trends
 Table 145. Glucocorticoid Injection Market Drivers
 Table 146. Glucocorticoid Injection Market Challenges
 Table 147. Glucocorticoid Injection Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Glucocorticoid Injection
 Figure 2. Global Glucocorticoid Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Glucocorticoid Injection Market Share by Type: 2025 & 2032
 Figure 4. Beclomethasone Injection Product Picture
 Figure 5. Betamethasone Injection Product Picture
 Figure 6. Budesonide Injection Product Picture
 Figure 7. Cortisone Injection Product Picture
 Figure 8. Dexamethasone Injection Product Picture
 Figure 9. Hydrocortisone Injection Product Picture
 Figure 10. Methylprednisolone Injection Product Picture
 Figure 11. Prednisolone Injection Product Picture
 Figure 12. Global Glucocorticoid Injection Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Glucocorticoid Injection Market Share by Application: 2025 & 2032
 Figure 14. Rheumatoid Arthritis
 Figure 15. Allergic Diseases
 Figure 16. Bronchial Asthma
 Figure 17. Autoimmune Disease
 Figure 18. Skin Diseases
 Figure 19. Others
 Figure 20. Global Glucocorticoid Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 21. Global Glucocorticoid Injection Market Size (US$ Million), 2021–2032
 Figure 22. Global Glucocorticoid Injection Sales (K Units), 2021–2032
 Figure 23. Global Glucocorticoid Injection Average Price (US$/Unit), 2021–2032
 Figure 24. Glucocorticoid Injection Report Years Considered
 Figure 25. Glucocorticoid Injection Sales Share by Manufacturers in 2025
 Figure 26. Global Glucocorticoid Injection Revenue Share by Manufacturers in 2025
 Figure 27. Top 5 and Top 10 Global Glucocorticoid Injection Players: Market Share by Revenue in Glucocorticoid Injection in 2025
 Figure 28. Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 29. Global Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 30. North America Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 31. North America Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 32. United States Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Canada Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Europe Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 35. Europe Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 36. Germany Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. France Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. U.K. Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Italy Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Russia Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Asia Pacific Glucocorticoid Injection Sales Market Share by Region (2021–2032)
 Figure 42. Asia Pacific Glucocorticoid Injection Revenue Market Share by Region (2021–2032)
 Figure 43. China Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Japan Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. South Korea Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. India Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Australia Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. China Taiwan Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Southeast Asia Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Latin America Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 51. Latin America Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 52. Mexico Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Brazil Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Argentina Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Colombia Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Middle East and Africa Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 57. Middle East and Africa Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 58. Turkey Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Saudi Arabia Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. UAE Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Global Sales Market Share of Glucocorticoid Injection by Type (2021–2032)
 Figure 62. Global Revenue Market Share of Glucocorticoid Injection by Type (2021–2032)
 Figure 63. Global Glucocorticoid Injection Price (US$/Unit) by Type (2021–2032)
 Figure 64. Global Sales Market Share of Glucocorticoid Injection by Application (2021–2032)
 Figure 65. Global Revenue Market Share of Glucocorticoid Injection by Application (2021–2032)
 Figure 66. Global Glucocorticoid Injection Price (US$/Unit) by Application (2021–2032)
 Figure 67. Glucocorticoid Injection Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension